These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A Novel AICDA Splice-Site Mutation in Two Siblings with HIGM2 Permits Somatic Hypermutation but Abrogates Mutational Targeting. Dirks J; Haase G; Cantaert T; Frey L; Klaas M; Rickert CH; Girschick H; Meffre E; Morbach H J Clin Immunol; 2022 May; 42(4):771-782. PubMed ID: 35246784 [TBL] [Abstract][Full Text] [Related]
3. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants. Durandy A; Peron S; Taubenheim N; Fischer A Hum Mutat; 2006 Dec; 27(12):1185-91. PubMed ID: 16964591 [TBL] [Abstract][Full Text] [Related]
4. A Novel Heterozygous Variant in AICDA Impairs Ig Class Switching and Somatic Hypermutation in Human B Cells and is Associated with Autosomal Dominant HIGM2 Syndrome. Della Mina E; Jackson KJL; Crawford AJI; Faulks ML; Pathmanandavel K; Acquarola N; O'Sullivan M; Kerre T; Naesens L; Claes K; Goodnow CC; Haerynck F; Kracker S; Meyts I; D'Orsogna LJ; Ma CS; Tangye SG J Clin Immunol; 2024 Feb; 44(3):66. PubMed ID: 38363477 [TBL] [Abstract][Full Text] [Related]
5. Separate domains of AID are required for somatic hypermutation and class-switch recombination. Shinkura R; Ito S; Begum NA; Nagaoka H; Muramatsu M; Kinoshita K; Sakakibara Y; Hijikata H; Honjo T Nat Immunol; 2004 Jul; 5(7):707-12. PubMed ID: 15195091 [TBL] [Abstract][Full Text] [Related]
6. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome. Caratão N; Cortesão CS; Reis PH; Freitas RF; Jacob CM; Pastorino AC; Carneiro-Sampaio M; Barreto VM Clin Immunol; 2013 Aug; 148(2):279-86. PubMed ID: 23803409 [TBL] [Abstract][Full Text] [Related]
8. Depletion of recombination-specific cofactors by the C-terminal mutant of the activation-induced cytidine deaminase causes the dominant negative effect on class switch recombination. Al Ismail A; Husain A; Kobayashi M; Honjo T; Begum NA Int Immunol; 2017 Dec; 29(11):525-537. PubMed ID: 29136157 [TBL] [Abstract][Full Text] [Related]
9. A Hyper-IgM Syndrome Mutation in Activation-Induced Cytidine Deaminase Disrupts G-Quadruplex Binding and Genome-wide Chromatin Localization. Yewdell WT; Kim Y; Chowdhury P; Lau CM; Smolkin RM; Belcheva KT; Fernandez KC; Cols M; Yen WF; Vaidyanathan B; Angeletti D; McDermott AB; Yewdell JW; Sun JC; Chaudhuri J Immunity; 2020 Nov; 53(5):952-970.e11. PubMed ID: 33098766 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies. Durandy A; Taubenheim N; Peron S; Fischer A Adv Immunol; 2007; 94():275-306. PubMed ID: 17560278 [TBL] [Abstract][Full Text] [Related]
11. Dissociation of in vitro DNA deamination activity and physiological functions of AID mutants. Shivarov V; Shinkura R; Honjo T Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15866-71. PubMed ID: 18832469 [TBL] [Abstract][Full Text] [Related]
12. Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Xu Z; Pone EJ; Al-Qahtani A; Park SR; Zan H; Casali P Crit Rev Immunol; 2007; 27(4):367-97. PubMed ID: 18197815 [TBL] [Abstract][Full Text] [Related]
13. Activation-induced deaminase (AID)-directed hypermutation in the immunoglobulin Smu region: implication of AID involvement in a common step of class switch recombination and somatic hypermutation. Nagaoka H; Muramatsu M; Yamamura N; Kinoshita K; Honjo T J Exp Med; 2002 Feb; 195(4):529-34. PubMed ID: 11854365 [TBL] [Abstract][Full Text] [Related]
14. AID mutant analyses indicate requirement for class-switch-specific cofactors. Ta VT; Nagaoka H; Catalan N; Durandy A; Fischer A; Imai K; Nonoyama S; Tashiro J; Ikegawa M; Ito S; Kinoshita K; Muramatsu M; Honjo T Nat Immunol; 2003 Sep; 4(9):843-8. PubMed ID: 12910268 [TBL] [Abstract][Full Text] [Related]
15. Identification of DNA cleavage- and recombination-specific hnRNP cofactors for activation-induced cytidine deaminase. Hu W; Begum NA; Mondal S; Stanlie A; Honjo T Proc Natl Acad Sci U S A; 2015 May; 112(18):5791-6. PubMed ID: 25902538 [TBL] [Abstract][Full Text] [Related]
16. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2. Imai K; Zhu Y; Revy P; Morio T; Mizutani S; Fischer A; Nonoyama S; Durandy A Clin Immunol; 2005 Jun; 115(3):277-85. PubMed ID: 15893695 [TBL] [Abstract][Full Text] [Related]
17. Pillars Article: Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme. Muramatsu M; Kinoshita K; Fagarasan S; Yamada S; Shinkai Y; Honjo T J Immunol; 2018 Nov; 201(9):2530-2540. PubMed ID: 30348658 [No Abstract] [Full Text] [Related]
18. Evolution of the immunoglobulin heavy chain class switch recombination mechanism. Chaudhuri J; Basu U; Zarrin A; Yan C; Franco S; Perlot T; Vuong B; Wang J; Phan RT; Datta A; Manis J; Alt FW Adv Immunol; 2007; 94():157-214. PubMed ID: 17560275 [TBL] [Abstract][Full Text] [Related]
19. The Common Key to Class-Switch Recombination and Somatic Hypermutation: Discovery of AID and Its Role in Antibody Gene Diversification. Leeman-Neill RJ; Lim J; Basu U J Immunol; 2018 Nov; 201(9):2527-2529. PubMed ID: 30348657 [No Abstract] [Full Text] [Related]
20. Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase. Zhu Y; Nonoyama S; Morio T; Muramatsu M; Honjo T; Mizutani S J Med Dent Sci; 2003 Mar; 50(1):41-6. PubMed ID: 12715918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]